EVERSANA and Waltz Health announce a merger to form a unified healthcare platform that redefines pharmaceutical commercialization and patient access. The move integrates Waltz Health’s software-powered drug-price marketplaces and direct-to-payer model into EVERSANA’s global commercialization services, creating a next-generation approach for drug access and value in the U.S. healthcare system. EVERSANA is a pioneering leader in the pharma commercialization industry, serving the top 50 pharma and biotech companies globally with a full suite of end-to-end commercialization capabilities. By embedding Waltz Health’s technology and broad payer footprint, the combined company is positioned to break through the industry’s misaligned incentives and fragmented patient experiences.
Read the full article: EVERSANA Merges with Waltz Health to Create a New Force in Pharma Commercialization and Prescription Drug Access //
Source: https://www.prnewswire.com/news-releases/eversana-merges-with-waltz-health-to-create-a-new-force-in-pharma-commercialization-and-prescription-drug-access-302538273.html